BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35907463)

  • 1. Galactomannan armed superparamagnetic iron oxide nanoparticles as a folate receptor targeted multi-functional theranostic agent in the management of cancer.
    R S; M Joseph M; Sen A; K RP; Bs U; Tt S
    Int J Biol Macromol; 2022 Oct; 219():740-753. PubMed ID: 35907463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
    Huang Y; Mao K; Zhang B; Zhao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of multiple injections on the efficacy and cytotoxicity of folate-targeted magnetite nanoparticles as theranostic agents for MRI detection and magnetic hyperthermia therapy of tumor cells.
    Soleymani M; Khalighfard S; Khodayari S; Khodayari H; Kalhori MR; Hadjighassem MR; Shaterabadi Z; Alizadeh AM
    Sci Rep; 2020 Feb; 10(1):1695. PubMed ID: 32015364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles.
    Zheng XC; Ren W; Zhang S; Zhong T; Duan XC; Yin YF; Xu MQ; Hao YL; Li ZT; Li H; Liu M; Li ZY; Zhang X
    Int J Nanomedicine; 2018; 13():1495-1504. PubMed ID: 29559778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapy.
    Zarrin A; Sadighian S; Rostamizadeh K; Firuzi O; Hamidi M; Mohammadi-Samani S; Miri R
    Int J Pharm; 2016 Mar; 500(1-2):62-76. PubMed ID: 26721723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A biocompatible glycol-capped nano-delivery system with stimuli-responsive drug release kinetics abrogates cancer cell survival.
    R S; Joseph MM; Pillai KR; G U P; T T S
    Int J Biol Macromol; 2020 Dec; 165(Pt A):568-581. PubMed ID: 32961196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer.
    Azhdarzadeh M; Atyabi F; Saei AA; Varnamkhasti BS; Omidi Y; Fateh M; Ghavami M; Shanehsazzadeh S; Dinarvand R
    Colloids Surf B Biointerfaces; 2016 Jul; 143():224-232. PubMed ID: 27015647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid-appended galactoxyloglucan-capped iron oxide nanoparticles as a biocompatible nanotheranostic agent for tumor-targeted delivery of doxorubicin.
    Unnikrishnan BS; Sen A; Preethi GU; Joseph MM; Maya S; Shiji R; Anusree KS; Sreelekha TT
    Int J Biol Macromol; 2021 Jan; 168():130-142. PubMed ID: 33278441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
    Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
    Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
    Kandasamy G; Maity D
    Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-Specific Endogenous Fe
    Fan Z; Jiang B; Zhu Q; Xiang S; Tu L; Yang Y; Zhao Q; Huang D; Han J; Su G; Ge D; Hou Z
    ACS Appl Mater Interfaces; 2020 Apr; 12(13):14884-14904. PubMed ID: 32167740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronan-modified superparamagnetic iron oxide nanoparticles for bimodal breast cancer imaging and photothermal therapy.
    Yang RM; Fu CP; Fang JZ; Xu XD; Wei XH; Tang WJ; Jiang XQ; Zhang LM
    Int J Nanomedicine; 2017; 12():197-206. PubMed ID: 28096667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer.
    Luo X; Peng X; Hou J; Wu S; Shen J; Wang L
    Int J Nanomedicine; 2017; 12():5331-5343. PubMed ID: 28794626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of superparamagnetic iron oxide/doxorubicin loaded chitosan nanoparticles as a promising glioblastoma theranostic tool.
    Gholami L; Tafaghodi M; Abbasi B; Daroudi M; Kazemi Oskuee R
    J Cell Physiol; 2019 Feb; 234(2):1547-1559. PubMed ID: 30145790
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Mortezazadeh T; Gholibegloo E; Khoobi M; Alam NR; Haghgoo S; Mesbahi A
    J Drug Target; 2020 Jun; 28(5):533-546. PubMed ID: 31842616
    [No Abstract]   [Full Text] [Related]  

  • 16. Polyvalent Folate-Dendrimer-Coated Iron Oxide Theranostic Nanoparticles for Simultaneous Magnetic Resonance Imaging and Precise Cancer Cell Targeting.
    Luong D; Sau S; Kesharwani P; Iyer AK
    Biomacromolecules; 2017 Apr; 18(4):1197-1209. PubMed ID: 28245646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization, Characterization and in vivo Evaluation of Paclitaxel-Loaded Folate-Conjugated Superparamagnetic Iron Oxide Nanoparticles.
    Gui G; Fan Z; Ning Y; Yuan C; Zhang B; Xu Q
    Int J Nanomedicine; 2021; 16():2283-2295. PubMed ID: 33776433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hierarchical self-assembly of magnetic nanoclusters for theranostics: Tunable size, enhanced magnetic resonance imagability, and controlled and targeted drug delivery.
    Nguyen DH; Lee JS; Choi JH; Park KM; Lee Y; Park KD
    Acta Biomater; 2016 Apr; 35():109-17. PubMed ID: 26884278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A superparamagnetic polymersome with extremely high T
    Liu Q; Song L; Chen S; Gao J; Zhao P; Du J
    Biomaterials; 2017 Jan; 114():23-33. PubMed ID: 27837682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimuli-responsive graphene oxide and methotrexate-loaded magnetic nanoparticles for breast cancer-targeted therapy.
    Dolatkhah M; Hashemzadeh N; Barar J; Adibkia K; Aghanejad A; Barzegar-Jalali M; Omidian H; Omidi Y
    Nanomedicine (Lond); 2021 Oct; 16(24):2155-2174. PubMed ID: 34565179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.